2008
DOI: 10.1016/j.jnutbio.2007.11.001
|View full text |Cite
|
Sign up to set email alerts
|

Soybean diet improves insulin secretion through activation of cAMP/PKA pathway in rats☆

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
7
2
1

Year Published

2009
2009
2019
2019

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(12 citation statements)
references
References 32 publications
2
7
2
1
Order By: Relevance
“…Soy bean and its isoflavones were earlier known to exhibit beneficial effects in correcting the hyperglycemia and preventing diabetic complications (Aboutabl et al, 2002;Ali, Velasquez, Hansen, Mohamed, & Bhathena, 2005;Blair, Henley, & Tabor, 2006;Lee, 2006;McCue et al, 2005;Palanisamy, Viswanathan, & Anuradha, 2008;Velso et al, 2008). The present observations now indicate a similar type of effect with its sterol component, but at a lower concentration.…”
Section: Resultssupporting
confidence: 67%
“…Soy bean and its isoflavones were earlier known to exhibit beneficial effects in correcting the hyperglycemia and preventing diabetic complications (Aboutabl et al, 2002;Ali, Velasquez, Hansen, Mohamed, & Bhathena, 2005;Blair, Henley, & Tabor, 2006;Lee, 2006;McCue et al, 2005;Palanisamy, Viswanathan, & Anuradha, 2008;Velso et al, 2008). The present observations now indicate a similar type of effect with its sterol component, but at a lower concentration.…”
Section: Resultssupporting
confidence: 67%
“…Prevention of aglycin against the loss of glucose tolerance and abnormal glucose levels in diabetic mice was hence in line with some studies that soybean peptide could improve glucose tolerance [22]. The possibility that aglycin maintained normoglycemia in these mice by increasing insulin secretion was ruled out because aglycin failed to increase insulin release in response to glucose challenge.…”
Section: Discussionsupporting
confidence: 64%
“…This is in contrast to our previous data whereby genistein administration for 1 month increased plasma insulin in males, 11 Several mechanisms have been postulated to explain genistein's stimulatory action on insulin secretion, including inhibition of tyrosine kinase activity 30 and activation of the cAMP/PKA ERK1/2 and PLC/PKC pathways. 31,32 Explaining the increase in insulin sensitivity in tissues is, as expected, primarily due to an increase in expression and translocation of the glucose transporter GLUT4. In skeletal muscle and L6 myotubes, several reports consistently show that genistein increases glucose uptake via up-regulation of both GLUT4 and insulinindependent mechanisms.…”
mentioning
confidence: 65%